Iovance Biotherapeutics
IOVA
Iovance Biotherapeutics is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
Iovance Biotherapeutics has been a target of short sellers for a while. The current short interest of 19.46% is slightly below the average of the last 12 months (23.67%).
Short Interest Trend
Share Price
Total NSP
19.46%
-3.27%
vs. last month
Also interesting? All insider buys at Iovance Biotherapeutics
Found an error? Questions? Ideas?